氨基酸β1-40可预测急性心肌梗塞患者的长期死亡率
Aneta Aleksova1,2, Alessandra Lucia Fluca1,2, Alessandro Pierri3
1Cardiothoracovascular Department Azienda Sanitaria Universitaria Giuliano Isontina Trieste Italy.
Journal of the American Heart Association
|April 3, 2025
概括
氨基酸β1-40 (Aβ1-40) 预测急性心肌梗塞 (AMI) 患者的死亡率,包括那些患有ST段升高心肌梗塞 (STEMI) 和非ST段升高心肌梗塞 (NSTEMI) 患者. 较高的Aβ1-40水平表明风险增加,有助于患者风险分层.
科学领域:
- 心血管医学 心血管医学
- 生物标志物 生物标志物
- 动脉样硬化研究 动脉样硬化研究
背景情况:
- 粉样蛋白β1-40 (Aβ1-40) 与动脉样硬化有关,影响了斑块的稳定性.
- 在急性心肌梗塞 (AMI) 中Aβ1-40的预后意义主要研究在非ST段升高心肌梗塞 (NSTEMI) 中.
研究的目的:
- 评估Aβ1-40的预后价值在真实世界的一群AMI患者 (STEMI和NSTEMI).
- 确定该患者群体中Aβ1-40水平升高的预测因子.
主要方法:
- 对1119名连续AMI患者 (68%的STEMI) 的分析.
- 在入院时测量血清Aβ1-40水平.
- 卡普兰-梅尔和考克斯的多变量分析来评估死亡风险和Aβ1-40作为预测因素.
- 开发一种名谱来预测高Aβ1-40水平.
主要成果:
- 中位数Aβ1-40为86.9 pg/mL,STEMI和NSTEMI之间没有差异.
- 较高Aβ1-40的预测因素包括年龄较大,射出分数较低,HbA1c较高和GFR较低.
- 在整体队列中,高Aβ1-40水平与明显更高的全因死亡率相关 (HR1.03,P=0.01).
- 在STEMI患者中,Aβ1-40是死亡的独立预测因子,但在NSTEMI患者中不是.
结论:
- 在急性心肌梗塞患者中,Aβ1-40作为死亡的独立预测因子.
- 测量Aβ1-40可以提高AMI患者的风险分层策略.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
71
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
71
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
38
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
38